Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients
Status:
Terminated
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This is a randomized Phase III study to evaluate the efficacy and safety of perifosine when
added to the combination of bortezomib and dexamethasone in multiple myeloma patients who
have relapsed on a prior bortezomib treatment regimen.